Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 3/20 | 0.59 |
| ▸ | FNTB | P49356 | 3/20 | 0.59 |
| ▸ | HTT | P42858 | 2/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | PTAFR | P25105 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.44 |
| ▸ | SETD7 | Q8WTS6 | 2/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.44 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.44 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.44 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.44 |
| ▸ | DRD1 | P21728 | 2/20 | 0.44 |
| ▸ | DRD3 | P35462 | 2/20 | 0.44 |
| ▸ | HTR1A | P08908 | 1/20 | 0.44 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.44 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.44 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.44 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7674798 | 0.99 | FNTA (0.58) | FNTAFNTBHTTCYP3A4PTAFR | |
| SCHEMBL7682329 | 0.88 | FNTA (0.57) | FNTAFNTBHTTCYP3A4PTAFR | |
| Hydrochloric Acid SCHEMBL7679240 | 0.87 | FNTA (0.56) | FNTAFNTBHTTCYP3A4PTAFR | |
| SCHEMBL7676763 | 0.86 | FNTA (0.55) | FNTAFNTBHTTCYP3A4PTAFR | |
| SCHEMBL9844279 | 0.85 | FNTA (0.54) | FNTAFNTBHTTCYP3A4PTAFR | |
| Hydrochloric Acid SCHEMBL9844228 | 0.85 | FNTA (0.54) | FNTAFNTBHTTCYP3A4PTAFR | |
| SCHEMBL9844244 | 0.84 | FNTA (0.53) | FNTAFNTBHTTCYP3A4PTAFR | |
| SCHEMBL9844384 | 0.84 | FNTA (0.53) | FNTAFNTBHTTCYP3A4PTAFR | |
| SCHEMBL9844251 | 0.84 | FNTA (0.53) | FNTAFNTBHTTCYP3A4PTAFR | |
| SCHEMBL7676741 | 0.84 | FNTA (0.53) | FNTAFNTBHTTCYP3A4PTAFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020151539-A1 | Novel heterocyclic compounds | JORGENSEN TINE KROGH (DK) | 2002-10-17 | — | — | US | claimed |
| US-6391890-B1 | ANALGESICS, ANTIINFLAMMATORY AGENTS, NON-INSULIN DEPENDENT DIABETES | NOVO NORDISK A/S (DK) | 2002-05-21 | — | — | US | claimed |
| EP-0991633-A1 | NOVEL HETEROCYCLIC COMPOUNDS | NOVO NORDISK A/S (DK) | 2000-04-12 | — | — | EP | claimed |
| WO-1999000376-A1 | NOVEL HETEROCYCLIC COMPOUNDS | NOVO NORDISK A/S (DK) | 1999-01-07 | — | — | WO | claimed |
| EP-0451772-A1 | Piperidine compounds, method for preparation thereof, and a pharamceutical composition comprising the same | HOKURIKU PHARMACEUTICAL CO., LTD. (JP) | 1991-10-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020151539-A1 | Novel heterocyclic compounds | IAPP, GPR119, NPY1R | FNTA 3191/4885FNTB 2306/4885HTT 1374/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.